Esperion Therapeutics Investor Relations Material
Latest events
Q3 2024
Esperion Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Esperion Therapeutics Inc
Access all reports
Esperion Therapeutics, Inc. is a pharmaceutical company focused on the research, development, and commercialization of therapies to treat cardiovascular and metabolic diseases. The company specializes in developing oral, non-statin medications aimed at lowering cholesterol levels and addressing other factors contributing to cardiovascular risk. The company is headquartered in Ann Arbor, Michigan, and its shares are listed on the NASDAQ.
Key slides for Esperion Therapeutics Inc
Corporate Presentation
Esperion Therapeutics Inc
Q1 2024
Esperion Therapeutics Inc
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
ESPR
Country
🇺🇸 United States